Toru Kawamoto Selected Research

Toru Kawamoto Research Topics

Disease

24	Neoplasms (Cancer) 01/2016 - 01/2002
15	Carcinoma (Carcinomatosis) 05/2015 - 03/2002
7	Neoplasm Metastasis (Metastasis) 01/2006 - 01/2002
5	Gallbladder Neoplasms (Gallbladder Cancer) 01/2016 - 09/2003
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020 - 06/2007
3	Infections 11/2017 - 11/2003
3	Carcinogenesis 01/2016 - 11/2003
3	Cholangiocarcinoma 06/2013 - 12/2008
2	Abdominal Pain (Pain, Abdominal) 06/2016 - 07/2004
2	Ischemia 10/2013 - 01/2006
2	Adenocarcinoma 08/2010 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2010
2	Colonic Neoplasms (Colon Cancer) 01/2006 - 09/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Pancreaticobiliary Maljunction 01/2016
1	Bile Duct Diseases (Bile Duct Disease) 06/2013
1	Hypoxia (Hypoxemia) 08/2010
1	Inflammation (Inflammations) 08/2008
1	Pancreatic Diseases (Pancreatic Disease) 08/2008
1	Lung Neoplasms (Lung Cancer) 11/2007
1	Adenoma (Adenomas) 03/2005
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2005
1	Colic (Abdominal Cramps) 09/2004
1	Diarrhea 07/2004
1	Proctocolitis (Hemorrhagic Proctocolitis) 07/2004
1	Hyperemia 07/2004
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 12/2003
1	Genomic Instability 11/2003

Drug/Important Bio-Agent (IBA)

9	Biological ProductsIBA 04/2014 - 03/2002
7	Messenger RNA (mRNA)IBA 01/2010 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2004
5	Proteins (Proteins, Gene)FDA Link 04/2014 - 04/2002
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2008 - 03/2002
3	ErbB Receptors (EGF Receptor)IBA 11/2007 - 08/2005
3	Monoclonal AntibodiesIBA 11/2004 - 01/2004
3	Cadherins (E-Cadherin)IBA 01/2004 - 01/2002
2	TOR Serine-Threonine KinasesIBA 05/2015 - 04/2007
2	LigandsIBA 11/2014 - 01/2010
2	wisteria lectinIBA 06/2013 - 07/2010
2	Polysaccharides (Glycans)IBA 05/2008 - 03/2005
2	Therapeutic UsesIBA 06/2007 - 04/2007
2	Prostaglandins EIBA 07/2003 - 04/2002
2	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 07/2003 - 04/2002
1	AcidsIBA 11/2017
1	Indicators and Reagents (Reagents)IBA 11/2017
1	Pyrantel Pamoate (Pyrantel Embonate)IBA 06/2016
1	phytobacteriomycin (PBM)IBA 01/2016
1	Keratins (Keratin)IBA 01/2016
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2015
1	pertuzumabIBA 04/2015
1	Small Interfering RNA (siRNA)IBA 04/2014
1	AcetylglucosamineIBA 04/2014
1	EnzymesIBA 04/2014
1	AsparagineIBA 04/2014
1	OligosaccharidesIBA 04/2014
1	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 04/2014
1	C-Reactive ProteinIBA 04/2014
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 06/2013
1	Contrast MediaIBA 08/2010
1	Oxygen (Dioxygen)IBA 08/2010
1	SonazoidIBA 08/2010
1	Mucin-1 (CA 15-3 Antigen)IBA 07/2010
1	cyclopamineIBA 01/2010
1	Zinc Finger Protein Gli2IBA 01/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2010
1	Immunotoxins (Immunotoxin)IBA 12/2008
1	Cell Surface ReceptorsIBA 12/2008
1	Cytotoxins (Cytolysins)IBA 12/2008
1	ExotoxinsIBA 12/2008
1	Interleukin-4 (Interleukin 4)IBA 12/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2007
1	apricoxibIBA 06/2007
1	Sirolimus (Rapamycin)FDA Link 04/2007
1	MacrolidesIBA 04/2007
1	E-SelectinIBA 01/2006
1	AntithrombinsIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Gefitinib (Iressa)FDA Link 08/2005
1	Tyrosine Kinase InhibitorsIBA 08/2005
1	UDP-GlcNAc GalNAc-peptide beta1,3-N-acetylglucosaminyltransferaseIBA 03/2005
1	GalactosamineIBA 03/2004
1	IsoenzymesIBA 03/2004
1	MucinsIBA 03/2004
1	Uridine Diphosphate (UDP)IBA 03/2004
1	Polypeptide N-acetylgalactosaminyltransferaseIBA 03/2004
1	Multidrug Resistance-Associated Protein 2IBA 12/2003
1	Carcinoembryonic AntigenIBA 12/2003
1	ParaffinIBA 11/2003
1	Mitochondrial DNA (mtDNA)IBA 11/2003
1	Formaldehyde (Formol)FDA Link 11/2003

Therapy/Procedure

8	Therapeutics 01/2020 - 03/2003
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2003
3	Lymph Node Excision (Lymph Node Dissection) 09/2004 - 12/2000
2	Radiotherapy 01/2020 - 01/2003
2	Adjuvant Chemotherapy 09/2004 - 03/2003
1	Cholecystectomy 01/2016
1	Intramuscular Injections 10/2013
1	Intravenous Administration 08/2010
1	Microbubbles 08/2010
1	Ligation 07/2004